Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,227 | -64,873 | -23,973 | N/A | N/A |
| Depreciation Amortization | 286 | 28 | 22 | N/A | N/A |
| Income taxes - deferred | -978 | -197 | -46 | N/A | N/A |
| Accounts payable and accrued liabilities | 8,823 | 1,006 | 119 | N/A | N/A |
| Other Working Capital | 18,328 | 13,926 | 1,762 | N/A | N/A |
| Other Operating Activity | -4,244 | -109 | 249 | 0 | 0 |
| Operating Cash Flow | $-81,012 | $-50,219 | $-21,867 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -233,908 | N/A | N/A | N/A | N/A |
| PPE Investments | -5,290 | -69 | -3 | N/A | N/A |
| Investing Cash Flow | $-239,198 | $-69 | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 159,571 | N/A | 10 | N/A | N/A |
| Other Financing Activity | 187,165 | 39,873 | 42,499 | 0 | 0 |
| Financing Cash Flow | $346,736 | $39,873 | $42,509 | $N/A | $N/A |
| Beginning Cash Position | 45,660 | 56,075 | 35,436 | N/A | N/A |
| End Cash Position | 72,186 | 45,660 | 56,075 | N/A | N/A |
| Net Cash Flow | $26,526 | $-10,415 | $20,639 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,012 | -50,219 | -21,867 | N/A | N/A |
| Capital Expenditure | -5,290 | -69 | -3 | N/A | N/A |
| Free Cash Flow | -86,302 | -50,288 | -21,870 | 0 | 0 |